We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.71B
1-Year Est. Return
65.19%
This Fund
S&P 500
This Quarter
Est. Return
-0.48%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$1.96B
AUM Growth
-$245M
(-11%)
Cap. Flow
-$182M
Cap. Flow
% of AUM
-9.27%
Top 10 Holdings %
Top 10 Hldgs %
35.51%
Holding
329
New
55
Increased
52
Reduced
80
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$19.7M |
| 2 |
Adobe
ADBE
|
+$9.76M |
| 3 |
Rio Tinto
RIO
|
+$8.18M |
| 4 |
Amazon
AMZN
|
+$7.79M |
| 5 |
GTLS
Chart Industries
GTLS
|
+$7.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$47.1M |
| 2 |
Estee Lauder
EL
|
+$22.2M |
| 3 |
Eli Lilly
LLY
|
+$21.5M |
| 4 |
Microsoft
MSFT
|
+$12.3M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$11.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.14% |
| 2 | Healthcare | 12.67% |
| 3 | Consumer Discretionary | 10.71% |
| 4 | Industrials | 9.69% |
| 5 | Miscellaneous | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
276
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-40,820
| Closed | -$3.72M |
|
277
Arrowhead Research
ARWR
$9.98B
| – | – |
-85,690
| Closed | -$3.06M |
|
278
Axalta
AXTA
$7.12B
| – | – |
-207,940
| Closed | -$6.82M |
|
279
Brunswick
BC
$4.46B
| – | – |
-53,130
| Closed | -$4.6M |
|
280
Belden
BDC
$4.35B
| – | – |
-35,200
| Closed | -$3.37M |
|
281
CBIZ
CBZ
$2.97B
| – | – |
-90,730
| Closed | -$4.83M |
|
282
Churchill Downs
CHDN
$5.62B
| – | – |
-23,430
| Closed | -$3.26M |
|
283
Coty
COTY
$2.33B
| – | – |
-399,130
| Closed | -$4.91M |
|
284
Cerence
CRNC
$363M
| – | – |
-211,553
| Closed | -$6.18M |
|
285
Corsair Gaming
CRSR
$1.45B
| – | – |
-219,020
| Closed | -$3.89M |
|
286
Digi International
DGII
$2.6B
| – | – |
-97,110
| Closed | -$3.83M |
|
|
287
Estee Lauder
EL
$34.8B
| – | – |
-113,210
| Closed | -$22.2M |
|
288
Enbridge
ENB
$106B
| – | – |
-5,970
| Closed | -$222K |
|
289
Exponent
EXPO
$3.2B
| – | – |
-27,220
| Closed | -$2.54M |
|
290
Fortune Brands Innovations
FBIN
$4.77B
| – | – |
-84,710
| Closed | -$6.09M |
|
291
Five Below
FIVE
$13B
| – | – |
-35,910
| Closed | -$7.06M |
|
292
Shift4
FOUR
$3.34B
| – | – |
-94,140
| Closed | -$6.39M |
|
293
Generac Holdings
GNRC
$10.3B
| – | – |
-22,280
| Closed | -$3.32M |
|
294
Haemonetics
HAE
$4.83B
| – | – |
-12,610
| Closed | -$1.07M |
|
295
Healthcare Services Group
HCSG
$1.5B
| – | – |
-289,310
| Closed | -$4.32M |
|
296
iShares US Medical Devices ETF
IHI
$3.26B
| – | – |
-157,940
| Closed | -$8.92M |
|
297
indie Semiconductor
INDI
$714M
| – | – |
-558,670
| Closed | -$5.25M |
|
298
Inspire Medical Systems
INSP
$2.16B
| – | – |
-32,190
| Closed | -$10.5M |
|
299
KB Home
KBH
$3.04B
| – | – |
-102,640
| Closed | -$5.31M |
|
300
Grand Canyon Education
LOPE
$4B
| – | – |
-49,490
| Closed | -$5.11M |
|
Similar funds
MSC
BC
FEG
HCM
OH
BCM
CCI
MCM
Castleark Management's Q3 2023 Portfolio in Review
As of Q3 2023, Castleark Management held 329 positions worth $1.96B, down 11% from $2.21B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Castleark Management withdrew a net $182M in Q3 2023, closing 55 positions and reducing 80 holdings. Its most notable exit was Estee Lauder, an estimated $22.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Castleark Management opened a new position in Chart Industries worth $7.61M.
- Castleark Management's largest Q3 2023 buy was Chart Industries: 44,970 shares worth $7.61M.
- Castleark Management added most to SLB Ltd in Q3 2023, an estimated $19.7M increase.
- Castleark Management's biggest Q3 2023 reduction was Nike, cutting an estimated $47.1M.
- Castleark Management fully exited Estee Lauder in Q3 2023, selling an estimated $22.2M.
- Castleark Management's ten largest holdings make up 36% of its $1.96B portfolio in Q3 2023.
- Castleark Management opened 55 new positions and closed 55 in Q3 2023.
- Castleark Management's portfolio value fell 11% quarter-over-quarter to $1.96B.
Based on Castleark Management's 13F filing for Q3 2023, filed 15 Nov 2023.